The NaV1.7 expression was found to be 400-fold higher than NaV1.5 and 25-fold higher than NaV1.6 in metastatic MTC cell line, MZ-CRC-1; and the trend was similar in primary MTC TT cells. This evidence concerns the gene SCN9A and medullary thyroid gland carcinoma.